Quarterly report pursuant to Section 13 or 15(d)

Common Stock and Employee Equity Plans (Tables)

v3.24.3
Common Stock and Employee Equity Plans (Tables) - USD ($)
$ in Millions
 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Equity [Abstract]    
Schedule of Common Shares Outstanding
Common Stock
Shares of common stock outstanding were as follows:
Three Months Ended Nine Months Ended
September 28,
2024		 September 30,
2023		 September 28,
2024		 September 30,
2023
(In millions)
Balance, beginning of period 1,618  1,614  1,616  1,612 
Common stock issued under employee equity plans 10  9  15  14 
Common stock repurchases for tax withholding on equity awards (3) (3) (4) (4)
Issuance of common stock upon warrant exercise —  —  —  1 
Repurchases of common stock (2) (5) (4) (8)
Balance, end of period 1,623  1,615  1,623  1,615 
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based Compensation
Stock-based compensation expense recorded in the condensed consolidated statements of operations was as follows: 
Three Months Ended Nine Months Ended
September 28,
2024		 September 30,
2023		 September 28,
2024		 September 30,
2023
(In millions)
Cost of sales $ 5  $ 6  $ 16  $ 24 
Research and development 267  260  809  721 
Marketing, general and administrative 79  87  243  265 
Total $ 351  $ 353  $ 1,068  $ 1,010 
 
Payments for Repurchase of Common Stock $ 606 $ 752